Table II.
Comorbidities (N = 1877)
| Comorbidities | n (%) |
|---|---|
| SCD | 27 (1.4) |
| Immunocompromising condition | 78 (3.7) |
| Hematopoietic stem cell transplant or cellular therapy recipient | 5 (0.2) |
| Solid organ transplant recipient | 16 (0.9) |
| Other immunocompromising condition (not transplanted) | 57 (3.0) |
| Malignancy (solid or liquid) | 26 (1.4) |
| Primary immunodeficiency | 3 (0.2) |
| Rheumatologic conditions | 10 (0.5) |
| Other/not specified | 18 (1.0) |
| Technology dependence | 6 (0.3) |
| Tracheostomy dependence | 1 (0.1) |
| Enteral feeding tube dependence | 5 (0.2) |
| Obesity | 131 (7.0) |
| Diabetes | 39 (2.1) |
| Neurologic disease | 123 (6.6) |
| Hypoxic-ischemic encephalopathy | 3 (0.2) |
| Neurodegenerative disease | 3 (0.2) |
| Seizure disorder | 39 (2.1) |
| Other/not specified | 79 (4.2) |
| CKD | 13 (0.7) |
| Pulmonary disease (excluding mild asthma) | 106 (5.6) |
| Moderate/severe asthma | 65 (3.5) |
| Bronchopulmonary dysplasia | 1 (0.1) |
| Cystic fibrosis | 3 (0.2) |
| Pulmonary hypertension | 1 (0.1) |
| Other/not specified | 36 (1.9) |
| Heart disease | 53 (2.8) |
| Congenital cardiac disease | 12 (0.6) |
| Cardiomyopathy | 3 (0.2) |
| Cardiovascular or coronary artery disease | 2 (0.1) |
| Hypertension | 13 (6.9) |
| Other/not specified | 25 (1.3) |
| Any prespecified comorbidity | 449 (24) |
| No prespecified comorbidity | 1428 (76) |